本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

2.27
-0.2150-8.67%
成交量:207.68万
成交额:484.56万
市值:2.49亿
市盈率:-13.32
高:2.55
开:2.47
低:2.27
收:2.48
52周最高:5.45
52周最低:2.27
股本:1.10亿
流通股本:8,539.15万
量比:1.16
换手率:2.43%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
净资产收益率:-4.77%
总资产收益率:-28.42%
市净率:0.67
市盈率(LYR):-1.13

数据加载中...

2025/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]